CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	2021 Notes	2022 Notes	Preferred Stock	Common stock	Common stock 2021 Notes	Common stock 2022 Notes	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital 2021 Notes	Additional Paid-In Capital 2022 Notes	Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2021				307,000	1,254,300
Balance at the beginning at Dec. 31, 2021	$ (8,572)			$ 1					$ 61,197			$ (69,770)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,070											5,070
Stock-based compensation	3,917								3,917
Conversion of stock (in shares)				(307,000)	307,000	206,400
Conversion of stock		$ 33,024		$ (1)					1	$ 33,024
Issuance of common stock upon vesting of restricted stock units (in shares)					15,479
Exercise of stock options (in shares)					7,225
Exercise of stock options	158								158
Merger and recapitalization, net of fees (in shares)					100,350
Merger and recapitalization, net of fees	27,997								27,997
Stockholder contribution for debt issuance costs	924								924
Escrow shares derivative liability (in shares)					81,260
Escrow shares derivative liability	(6,867)								(6,867)
Private warrants derivative liability	(3,916)								(3,916)
Forward share purchase agreement derivative liability (in shares)					193,050
Forward share purchase agreement derivative liability	(14,170)								(14,170)
Stockholder earnout rights derivative liability	(26,131)								(26,131)
Settlement of forward share purchase agreement derivative liability	$ (17,841)								(17,841)
Purchase of treasury stock (in shares)								(154,055)
Purchase of treasury stock								$ (31,663)	31,663
Shares canceled (in shares)					(1,298)
Balance at the end (in shares) at Dec. 31, 2022	2,163,766			0	2,163,766			(154,055)
Balance at the end at Dec. 31, 2022	$ (6,407)			$ 0	$ 0			$ (31,663)	89,956			(64,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(9,498)											(9,498)
Stock-based compensation	2,955								2,955
Conversion of stock (in shares)							60,265
Conversion of stock			$ 324								$ 324
Reverse stock split , Shares					34,192
Reverse stock split					$ 0				0
Issuance of Common Stock under ESPP (in shares)					20,142
Issuance of Common Stock under ESPP	168								168
Issuance of common stock upon vesting of restricted stock units (in shares)					114,203
Balance at the end (in shares) at Dec. 31, 2023				0	2,392,568			(154,055)
Balance at the end at Dec. 31, 2023	$ (12,458)			$ 0	$ 0			$ (31,663)	$ 93,403			$ (74,198)